BRCA1 is a nuclear polypeptide to suppress familial breast and ovarian cancers. Accumulated evidence suggests that BRCA1 participates in DNA damage response. However, the molecular mechanisms by which BRCA1 participates in DNA damage response remain elusive. Recently, we have identified two new BRCA1 partners, RAP80 and CCDC98. Both RAP80 and CCDC98 associate with BRCA1 BRCT domain and participate in DNA damage response. Functionally, RAP80 and CCDC98 facilitate BRCA1's translocation to DNA damage sites. To search for the signals that recruit this BRCA1 complex to the DNA damage lesions, we have found that BRCA1-associated protein RAP80 recognizes ubiquitinated histone H2A and H2B. And both histone H2A and H2B are further ubiquitinated following DNA damage. In addition, we have identified two biallelic missense mutations and one truncation mutation of RAP80 gene in breast and ovarian cancer cells, suggesting that RAP80 could be another breast and ovarian tumors suppressor in BRCA1-dependent pathway. Thus, we hypothesize that recognition of ubiquitinated histone by RAP80 is the molecular basis that loads BRCA1 to DNA damage sites, which regulates proper DNA damage response, protects genomic integrity and prevents breast and ovarian tumor development. We propose following experiments to examine our hypothesis.
Aim1 : To examine the molecular mechanism by which RAP80 and CCDC98 target BRCA1 to DNA damage lesions.
Aim2 : To examine the functional defects of RAP80 mutations in BRCA1-dependent DNA damage response.
Aim3 : To examine the role of RAP80 in tumor prevention. In summary, studies outlined here will not only reveal the molecular mechanism by which BRCA1 participates in DNA damage response, but also identify the functional partners of BRCA1 in tumor suppression.
Accumulated evidence suggests that BRCA1 protects genomic integrity in response to DNA double strand breaks. Here, we have identified two BRCA1 partners, CCDC98 and RAP80, which participate in DNA damage response. In this proposal, we plan to not only dissect the molecular mechanism of this BRCA1 complex in DNA damage response, but also examine the role of this complex in tumorigenesis in vivo.
|Li, M; Yu, X (2015) The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy. Oncogene 34:3349-56|
|Luo, Tao; Cui, Shijun; Bian, Chunjing et al. (2014) Crosstalk between TGF-?/Smad3 and BMP/BMPR2 signaling pathways via miR-17-92 cluster in carotid artery restenosis. Mol Cell Biochem 389:169-76|
|Bian, Chunjing; Yu, Xiaochun (2014) PGC7 suppresses TET3 for protecting DNA methylation. Nucleic Acids Res 42:2893-905|
|Chen, Yibin; Chen, Qiang; McEachin, Richard C et al. (2014) H2A.B facilitates transcription elongation at methylated CpG loci. Genome Res 24:570-9|
|Zhang, Feng; Chen, Yibin; Li, Mo et al. (2014) The oligonucleotide/oligosaccharide-binding fold motif is a poly(ADP-ribose)-binding domain that mediates DNA damage response. Proc Natl Acad Sci U S A 111:7278-83|
|Osterman, Michael; Kathawa, Deion; Liu, Diangang et al. (2014) Elevated DNA damage response in pancreatic cancer. Histochem Cell Biol 142:713-20|
|Li, Mo; Yu, Xiaochun (2013) Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation. Cancer Cell 23:693-704|
|Li, Mo; Lu, Lin-Yu; Yang, Chao-Yie et al. (2013) The FHA and BRCT domains recognize ADP-ribosylation during DNA damage response. Genes Dev 27:1752-68|
|Chen, Qiang; Chen, Yibin; Bian, Chunjing et al. (2013) TET2 promotes histone O-GlcNAcylation during gene transcription. Nature 493:561-4|
|Liu, Chao; Wu, Jiaxue; Paudyal, Sharad C et al. (2013) CHFR is important for the first wave of ubiquitination at DNA damage sites. Nucleic Acids Res 41:1698-710|
Showing the most recent 10 out of 23 publications